➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Merck
Colorcon
Express Scripts
McKesson

Last Updated: August 12, 2020

DrugPatentWatch Database Preview

Technetium tc-99m sestamibi kit - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for technetium tc-99m sestamibi kit and what is the scope of freedom to operate?

Technetium tc-99m sestamibi kit is the generic ingredient in three branded drugs marketed by Lantheus Medcl, Cardinal Health 414, Curium, Jubilant Draximage, and Sun Pharm Inds Inc, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for technetium tc-99m sestamibi kit. Five suppliers are listed for this compound.

Summary for technetium tc-99m sestamibi kit
Recent Clinical Trials for technetium tc-99m sestamibi kit

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Mayo ClinicPhase 4
National Center for Research Resources (NCRR)Phase 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2

See all technetium tc-99m sestamibi kit clinical trials

Pharmacology for technetium tc-99m sestamibi kit

US Patents and Regulatory Information for technetium tc-99m sestamibi kit

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Inc TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 079157-001 Jul 10, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Curium TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078098-001 Sep 22, 2008 AP RX No No   Start Trial   Start Trial   Start Trial
Cardinal Health 414 TECHNETIUM TC 99M SESTAMIBI technetium tc-99m sestamibi kit INJECTABLE;INJECTION 078809-001 Apr 28, 2009 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for technetium tc-99m sestamibi kit

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997   Start Trial   Start Trial
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990   Start Trial   Start Trial
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997   Start Trial   Start Trial
Lantheus Medcl CARDIOLITE technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-001 Dec 21, 1990   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Harvard Business School
Colorcon
McKinsey
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.